S&P Futures
4,114.50-5.00(-0.12%)Dow Futures
33,655.00-27.00(-0.08%)Nasdaq Futures
13,819.00-10.50(-0.08%)
Pfizer Inc. (PFE)
Chart Events
Performance Outlook
| Previous Close | 35.96 |
| Open | 35.90 |
| Bid | 36.61 x 900 |
| Ask | 36.61 x 3100 |
| Day's Range | 35.90 - 36.81 |
| 52 Week Range | 29.99 - 43.08 |
| Volume | 31,686,882 |
| Avg. Volume | 32,331,285 |
| Market Cap | 204.161B |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | 21.44 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.56 (4.26%) |
| Ex-Dividend Date | Jan 28, 2021 |
| 1y Target Est | N/A |
Fair Value
Related Research
- Reuters
South African variant may evade protection from Pfizer vaccine, Israeli study says
The coronavirus variant discovered in South Africa may evade the protection provided by Pfizer/BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is very low and the research has not been peer reviewed. The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel's largest healthcare provider, Clalit. But among patients who had received two doses of the vaccine, the variant's prevalence rate was eight times higher than those unvaccinated - 5.4% versus 0.7%.
- Reuters
UPDATE 1-South African variant may evade protection from Pfizer vaccine, Israeli study says
The coronavirus variant discovered in South Africa may evade the protection provided by Pfizer/BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is very low and the research has not been peer reviewed. The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel's largest healthcare provider, Clalit. But among patients who had received two doses of the vaccine, the variant's prevalence rate was eight times higher than those unvaccinated - 5.4% versus 0.7%.
- Motley Fool
3 Great Dividend Stocks to Buy Right Now
You really only have to look for two things when considering dividend stocks. Sure, there are other characteristics of dividend stocks that are nice to have. A track record of dividend increases is another big plus.
